Cargando…

Coenzyme Q10 and Its Therapeutic Potencies Against COVID-19 and Other Similar Infections: A Molecular Review

Purpose: New lethal coronavirus disease 2019 (COVID-19), currently, has been converted to a disastrous pandemic worldwide. As there has been found no definitive treatment for the infection in this review we focused on molecular aspects of coenzyme Q(10) (CoQ(10)) and possible therapeutic potencies o...

Descripción completa

Detalles Bibliográficos
Autores principales: Fakhrolmobasheri, Mohammad, Hosseini, Mahnaz-Sadat, Shahrokh, Seyedeh-Ghazal, Mohammadi, Zahra, Kahlani, Mohammad-Javad, Majidi, Seyed-Erfan, Zeinalian, Mehrdad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278218/
https://www.ncbi.nlm.nih.gov/pubmed/37342382
http://dx.doi.org/10.34172/apb.2023.026
Descripción
Sumario:Purpose: New lethal coronavirus disease 2019 (COVID-19), currently, has been converted to a disastrous pandemic worldwide. As there has been found no definitive treatment for the infection in this review we focused on molecular aspects of coenzyme Q(10) (CoQ(10)) and possible therapeutic potencies of CoQ(10) against COVID-19 and similar infections. Methods: This is a narrative review in which we used some authentic resources including PubMed, ISI, Scopus, Science Direct, Cochrane, and some preprint databases, the molecular aspects of CoQ(10) effects, regarding to the COVID-19 pathogenesis, have been analyzed and discussed. Results: CoQ(10) is an essential cofactor in the electron transport chain of the phosphorylative oxidation system. It is a powerful lipophilic antioxidant, anti-apoptotic, immunomodulatory and anti-inflammatory supplement which has been tested for the management and prevention of a variety of diseases particularly diseases with inflammatory pathogenesis. CoQ(10) is a strong anti-inflammatory agent which can reduce tumor necrosis factor-α (TNF-α), interleukin (IL)- 6, C-reactive protein (CRP), and other inflammatory cytokines. The cardio-protective role of CoQ(10) in improving viral myocarditis and drug induced cardiotoxicity has been determined in different studies. CoQ(10) could also improve the interference in the RAS system caused by COVID-19 through exerting anti-Angiotensin II effects and decreasing oxidative stress. CoQ(10) passes easily through blood–brain barrier (BBB). As a neuroprotective agent CoQ(10) can reduce oxidative stress and modulate the immunologic reactions. These properties may help to reduce CNS inflammation and prevent BBB damage and neuronal apoptosis in COVID-19 patients. Conclusion: CoQ(10) supplementation may prevent the COVID-19-induced morbidities with a potential protective role against the deleterious consequences of the disease, further clinical evaluations are encouraged.